Recurrent Non-small Cell Lung Cancer Terminated Phase 2 / 3 Trials for Docetaxel (DB01248)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01774578Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung CancerTreatment